Literature DB >> 25197397

Synchronous gastric and sebaceous cancers, a rare manifestation of MLH1-related Muir-Torre syndrome.

Jiří Svec1, Lucie Schwarzová2, Bohumila Janošíková2, Jitka Stekrová2, Václav Mandys3, Milan Kment4, Pavel Vodička5.   

Abstract

Muir-Torre syndrome (MTS), a rare variant of the hereditary non polyposis colorectal cancer syndrome, is an autosomal dominant genodermatosis characterised by coincidence of sebaceous gland neoplasms (sebaceous adenoma, epithelioma, or carcinoma) and at least one internal malignancy. The underlying cause of MTS is a germline mutation in DNA mismatch repair genes MSH2, MLH1 and MSH6. We report the case of a 52-year-old caucasian woman with the development of metachronous colon cancer at the age of 38 years, uterine cancer at the age of 43 years, and unique occurrence of synchronous gastric and sebaceous carcinomas related to germline point mutation c. 2194A>T in the last exon of MLH1 gene, resulting in truncated protein in C-terminal region p. Lys732X due to premature stop codon. This mutation, not previously reported in MTS, disrupts the function of MutL complexes presumably by preventing the interaction with PMS1/PMS2 and impairing the endonuclease active site. This case points out the importance of sebaceous neoplasia, especially sebaceous adenocarcinoma, as cutaneous markers of MTS for timely implementation of cancer screening programs.

Entities:  

Keywords:  MLH1; Muir-Torre syndrome; gastric cancer; germline mutation; sebaceous adenocarcinoma

Mesh:

Substances:

Year:  2014        PMID: 25197397      PMCID: PMC4152087     

Source DB:  PubMed          Journal:  Int J Clin Exp Pathol        ISSN: 1936-2625


  21 in total

1.  Two novel germline mutations (Y548X and K732X) of the MLH1 gene in Czech patients with hereditary nonpolyposis colorectal cancer.

Authors:  J Hajer; A Kepelová; Z Zádorová; M Kment
Journal:  Hum Mutat       Date:  2000-08       Impact factor: 4.878

2.  The genetic basis of Muir-Torre syndrome includes the hMLH1 locus.

Authors:  B Bapat; L Xia; L Madlensky; A Mitri; P Tonin; S A Narod; S Gallinger
Journal:  Am J Hum Genet       Date:  1996-09       Impact factor: 11.025

3.  Structure of the MutLα C-terminal domain reveals how Mlh1 contributes to Pms1 endonuclease site.

Authors:  Emeric Gueneau; Claudine Dherin; Pierre Legrand; Carine Tellier-Lebegue; Bernard Gilquin; Pierre Bonnesoeur; Floriana Londino; Cathy Quemener; Marie-Hélene Le Du; Josan A Márquez; Mireille Moutiez; Muriel Gondry; Serge Boiteux; Jean-Baptiste Charbonnier
Journal:  Nat Struct Mol Biol       Date:  2013-02-24       Impact factor: 15.369

4.  Multiple sebaceous tumors.

Authors:  D Torre
Journal:  Arch Dermatol       Date:  1968-11

Review 5.  Muir-Torre syndrome: case report of a patient with concurrent jejunal and ureteral cancer and a review of the literature.

Authors:  S Akhtar; K K Oza; S A Khan; J Wright
Journal:  J Am Acad Dermatol       Date:  1999-11       Impact factor: 11.527

6.  Multiple primary carcinomata of the colon, duodenum, and larynx associated with kerato-acanthomata of the face.

Authors:  E G Muir; A J Bell; K A Barlow
Journal:  Br J Surg       Date:  1967-03       Impact factor: 6.939

7.  Functional domains of the Saccharomyces cerevisiae Mlh1p and Pms1p DNA mismatch repair proteins and their relevance to human hereditary nonpolyposis colorectal cancer-associated mutations.

Authors:  Q Pang; T A Prolla; R M Liskay
Journal:  Mol Cell Biol       Date:  1997-08       Impact factor: 4.272

8.  New clinical criteria for hereditary nonpolyposis colorectal cancer (HNPCC, Lynch syndrome) proposed by the International Collaborative group on HNPCC.

Authors:  H F Vasen; P Watson; J P Mecklin; H T Lynch
Journal:  Gastroenterology       Date:  1999-06       Impact factor: 22.682

Review 9.  DNA mismatch repair and the significance of a sebaceous skin tumor for visceral cancer prevention.

Authors:  Roland Kruse; Thomas Ruzicka
Journal:  Trends Mol Med       Date:  2004-03       Impact factor: 11.951

10.  Structure of the human MSH2 locus and analysis of two Muir-Torre kindreds for msh2 mutations.

Authors:  R D Kolodner; N R Hall; J Lipford; M F Kane; M R Rao; P Morrison; L Wirth; P J Finan; J Burn; P Chapman
Journal:  Genomics       Date:  1994-12       Impact factor: 5.736

View more
  2 in total

Review 1.  Cutaneous manifestation of gastrointestinal disease.

Authors:  Maral Rahvar; Justin Kerstetter
Journal:  J Gastrointest Oncol       Date:  2016-04

2.  Urothelial Carcinoma Recurrence in an Ileal Neobladder Nine Years after Primary Surgery with Muir-Torre Syndrome.

Authors:  Floryn Cherbanyk; Marc Prod'homme; Edgardo Pezzetta; Bernard Chevaux; Anass Anaye; Jean-Joseph Boillat
Journal:  Case Rep Urol       Date:  2016-03-30
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.